|
|
|||||||
|
|
|
||||||
|
|
|
||||||
|
|
|||||||
|
|
|||||||
|
|
|
|
|
|
|
|
|
| Infiltrating Lobular Carcinoma | ||
|
Definition of terms:
Carcinoma - Cancer cells that start in the surface layers or lining of the ducts
Hormonal Therapy - Treatment with hormones or anti-hormonal medications Infiltrating - Cells that
go through the walls of the lobules
Invasive - Cells that have grown into surrounding tissues
Lymph Nodes - Pea-like areas in the lymphatic system that act as filters for the body's
cellular waste; lymph nodes under the arms filter the waste from the majority
of breast tissues
Lobular - Found in the lower parts of the ducts where the milk is produced
Malignant - Cancerous; a threat to the body
Mastectomy - Surgical removal of a breast
Metastasis - Spread of cancer to other parts of the body
Tumor - Excessive growth of cells that create a lump; may be cancerous or non-cancerous.
Infiltrating lobular carcinoma accounts for about 5 percent of all malignant,
invasive cancers. It occurs most frequently in women between the ages of 45 and
56. The tumor
|
grows in the terminal (last part) of the lobules where milk is produced. It
usually does not show up on mammography and may feel like a thickening in the
upper-outer quarter of the breast (from the nipple to under the arm) as it
infiltrates the walls of the lobules. In about 30% of cases, this cancer is
frequently found in the opposite breast. It is often found in other parts of
the same breast (multicentric). Late signs of a large tumor area may be the
retraction or puckering of the skin over the area. Most tumors are positive for
estrogen and progesterone receptors and thus respond well to hormonal therapy.
Infiltrating lobular carcinoma sometimes has an increased incidence of
spreading to the uterus and ovaries.
Surgery may range from a mastectomy to bilateral (both breasts) modified radical
mastectomy because of the high risk of cancer being in other parts of the
breast and because it is frequently found in the opposite breast. Treatment
options will vary according to the size of the tumor, lymph node involvement,
estrogen/progesterone receptor status, age and menopausal status of the
patient.
|
|
